Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M. Birch, Joe N. Kornegay, Courtney Shanks et al.|Science Translational Medicine|2023Cited by 68
Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx MiceTahnee L. Kennedy, Kay E. Davies, Simon Guiraud et al.|Molecular Therapy — Methods & Clinical Development|2018Cited by 31
A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic <i>Dmd</i> deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathyTatianna Wai Ying Wong, Ronald D. Cohn, Abdalla Ahmed et al.|Disease Models & Mechanisms|2020Cited by 27
SGT-001 Micro-dystrophin gene therapy for Duchenne muscular dystrophyJoel Schneider, Carl Morris, Jorge González et al.|Neuromuscular Disorders|2017Cited by 20
Quantification of microdystrophin and correlation to circulating biomarkersKristy J. Brown, Carl Morris, Michael W. Lawlor et al.|Neuromuscular Disorders|2017Cited by 1